Last reviewed · How we verify

NCT05521555

Return to Work After Total Knee Arthroplasty in Young Patients

Status unknown Last updated 30 August 2022
What this trial tests

trial testing Total knee arthroplasty in Knee Arthritis in 200 participants. Status unknown.

Timeline
20 July 2022
Primary endpoint
10 September 2022
20 September 2022

Quick facts

Lead sponsorCentral Hospital, Nancy, France
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date20 July 2022
Primary completion10 September 2022
Estimated completion20 September 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 to 55, any sex, with Knee Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study takes its base in the augmenting number of primary total knee arthroplasty in the world whom quality and survey had permit to widen their indications to younger patients who are in the age of professional activity. This work will focus on young patients under 55 who had had primary total knee arthroplasty, retrospectively, over the past 10 years, to determine the factors influencing early or late return to work, depending of socio economics factors. This will optimize the information for the patient, and prepare him if necessary for a long work stop, and possibly obtain a better satisfaction for him.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Total knee arthroplasty

Trials testing the same drug.

Other recruiting trials for Knee Arthritis

Currently open trials in the same condition.

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing